Shift in IgG Subclasses as a Tumor Marker in Head and Neck Cancer
Author Information
Author(s): W. Anderhuber, W. Steinschifter, E. Schauenstein, K. Schauenstein, A. Gotschuli
Primary Institution: University of Graz, Austria
Hypothesis
The shift in serum IgG subclasses can serve as a diagnostic marker for squamous cell carcinoma of the head and neck.
Conclusion
The shift in IgG subclasses may be useful for diagnosing and monitoring squamous cell carcinoma of the head and neck.
Supporting Evidence
- The mean %IgGl for patients was significantly lower than that of healthy controls.
- The overall diagnostic sensitivity was 70% with a specificity of 75%.
- Postoperative monitoring showed 83% correct diagnoses in patients with recurrent disease.
Takeaway
Doctors found that changes in certain proteins in the blood can help identify a type of throat cancer and track its progress.
Methodology
An affinity chromatography technique was used to measure IgG subclasses in serum from patients and healthy controls.
Participant Demographics
110 patients with squamous cell carcinoma and 179 healthy controls.
Statistical Information
P-Value
p<0.0005
Statistical Significance
p<0.0005
Want to read the original?
Access the complete publication on the publisher's website